1. Consumption upgrades and demand increases.With the increase of national income, people pay more and more attention to health and are also willing to spend more money on health care products and medicines. This provides a broad market space for the development of pharmacies. Policy support, market standardization.
2. The reasons for more and more pharmacies are as follows: ordinary people have needs. Most people's medical model is "go to the hospital for major diseases and go to the pharmacy for minor diseases". If it's just some minor problems, many people will not choose to go to crowded hospitals, but go to pharmacies to buy some targeted drugs.
3. More and more pharmacies in China are opening, mainly because with the improvement of people's health awareness, pharmacies have become an important place for people's daily health care and disease treatment. In addition, pharmacy operators have seen the high profits of the pharmaceutical industry and the great potential of the market, so they have invested in opening pharmacies, hoping to get a share in this field.
In addition, pharmacies also have a more profitable project, that is Sell imported products. For example, some unknown imported drugs, medical devices, etc., because the price of such products is not transparent, it is relatively easier to raise the unit price and the profit is higher.
Therefore, according to the author's analysis of Chinese chain pharmacies, the most suitable profit model for Chinese chain pharmacies is the high-product profit model, because it can be applied to any pharmaceutical commercial enterprise. Only by promoting high-profit products can you increase profits. If you have a deep understanding of China's drug marketing environment, there are a lot of opportunities for high-profit products.
By selling drugs, pharmacies can complete basic business revenue, at least ensure their own pharmacy operating costs and make certain profits. The development model of health care products and drugs can fully support the operation of a pharmacy, and the profits they earn are also very obvious.
The high profit of pharmacies is an open secret, but I guess many people can't imagine how high it is. We take a certainFor example, the factory price of a box of brand cold medicine is about 5 yuan, but it can be sold for 29 yuan in pharmacies.
The profit model of self-branded products is mainly promoted by high gross profit. The next evolution is the profit model mainly based on self-branded products.
1. Yixintang is a brand of Yunnan Hongxiang Pharmaceutical Co., Ltd., which began in 1981. After 32 years of development, it has now become a large-scale joint-stock pharmaceutical enterprise group integrating traditional Chinese medicine planting, processing, Chinese and Western pharmaceutical research and development, production, wholesale, retail chain operation and medical industry.
2. It is understood that Yixintang, founded in 2000, currently has more than 2,400 chain pharmacies across the country. In Yunnan Province alone, Yixintang pharmacies have more than 1,800, forming a national large-scale pharmaceutical retail enterprise spanning Yunnan, Guizhou, Sichuan, Chongqing, Guizhou, Jin and other provinces, regions and cities, and has become a national It has the largest chain pharmacy brand of direct pharmacies.
3. Yunnan Shuanghe Pharmaceutical Co., Ltd. is a warship of Beijing Shuanghe, a pharmaceutical aircraft carrier deployed in the southwestern thear zone. It is a new type of company with the market as the core, modern medical technology as the guide, and financial support as the framework. It is a pharmaceutical professional company with a large variety of drugs in the southwest region.
4. The biggest one should be Yixintang chain bar. His family cooperates with Kunming Medical Insurance. When everyone applied for medical insurance, they were given Zhang Yixintang membership card, Khan~~.Yixintang is a pharmaceutical chain brand under Yunnan Hongxiang Pharmaceutical.
5. Ding Ding Kuaiyao Ding Ding Kuaiyao is an O2O-based medical and health Internet product. It is a third-party information display platform that assists pharmacies in providing convenient services. There are two versions, IOS and Android, and has been launched in major application markets.
HS code-driven letter of credit checks-APP, download it now, new users will receive a novice gift pack.
1. Consumption upgrades and demand increases.With the increase of national income, people pay more and more attention to health and are also willing to spend more money on health care products and medicines. This provides a broad market space for the development of pharmacies. Policy support, market standardization.
2. The reasons for more and more pharmacies are as follows: ordinary people have needs. Most people's medical model is "go to the hospital for major diseases and go to the pharmacy for minor diseases". If it's just some minor problems, many people will not choose to go to crowded hospitals, but go to pharmacies to buy some targeted drugs.
3. More and more pharmacies in China are opening, mainly because with the improvement of people's health awareness, pharmacies have become an important place for people's daily health care and disease treatment. In addition, pharmacy operators have seen the high profits of the pharmaceutical industry and the great potential of the market, so they have invested in opening pharmacies, hoping to get a share in this field.
In addition, pharmacies also have a more profitable project, that is Sell imported products. For example, some unknown imported drugs, medical devices, etc., because the price of such products is not transparent, it is relatively easier to raise the unit price and the profit is higher.
Therefore, according to the author's analysis of Chinese chain pharmacies, the most suitable profit model for Chinese chain pharmacies is the high-product profit model, because it can be applied to any pharmaceutical commercial enterprise. Only by promoting high-profit products can you increase profits. If you have a deep understanding of China's drug marketing environment, there are a lot of opportunities for high-profit products.
By selling drugs, pharmacies can complete basic business revenue, at least ensure their own pharmacy operating costs and make certain profits. The development model of health care products and drugs can fully support the operation of a pharmacy, and the profits they earn are also very obvious.
The high profit of pharmacies is an open secret, but I guess many people can't imagine how high it is. We take a certainFor example, the factory price of a box of brand cold medicine is about 5 yuan, but it can be sold for 29 yuan in pharmacies.
The profit model of self-branded products is mainly promoted by high gross profit. The next evolution is the profit model mainly based on self-branded products.
1. Yixintang is a brand of Yunnan Hongxiang Pharmaceutical Co., Ltd., which began in 1981. After 32 years of development, it has now become a large-scale joint-stock pharmaceutical enterprise group integrating traditional Chinese medicine planting, processing, Chinese and Western pharmaceutical research and development, production, wholesale, retail chain operation and medical industry.
2. It is understood that Yixintang, founded in 2000, currently has more than 2,400 chain pharmacies across the country. In Yunnan Province alone, Yixintang pharmacies have more than 1,800, forming a national large-scale pharmaceutical retail enterprise spanning Yunnan, Guizhou, Sichuan, Chongqing, Guizhou, Jin and other provinces, regions and cities, and has become a national It has the largest chain pharmacy brand of direct pharmacies.
3. Yunnan Shuanghe Pharmaceutical Co., Ltd. is a warship of Beijing Shuanghe, a pharmaceutical aircraft carrier deployed in the southwestern thear zone. It is a new type of company with the market as the core, modern medical technology as the guide, and financial support as the framework. It is a pharmaceutical professional company with a large variety of drugs in the southwest region.
4. The biggest one should be Yixintang chain bar. His family cooperates with Kunming Medical Insurance. When everyone applied for medical insurance, they were given Zhang Yixintang membership card, Khan~~.Yixintang is a pharmaceutical chain brand under Yunnan Hongxiang Pharmaceutical.
5. Ding Ding Kuaiyao Ding Ding Kuaiyao is an O2O-based medical and health Internet product. It is a third-party information display platform that assists pharmacies in providing convenient services. There are two versions, IOS and Android, and has been launched in major application markets.
Sourcing opportunities filtered by HS code
author: 2024-12-23 22:26HS code-based compliance in Asia-Pacific
author: 2024-12-23 21:27Trade data-driven logistics planning
author: 2024-12-23 20:46Import data by HS code and country
author: 2024-12-23 20:07Real-time freight schedule optimization
author: 2024-12-23 19:54How to leverage big data in trade
author: 2024-12-23 22:00Country-wise HS code compliance tips
author: 2024-12-23 21:56How to comply with dual-use regulations
author: 2024-12-23 21:33How to identify correct HS codes
author: 2024-12-23 21:24Import restrictions by HS code category
author: 2024-12-23 20:50274.73MB
Check347.75MB
Check866.48MB
Check638.79MB
Check726.97MB
Check928.93MB
Check148.25MB
Check599.18MB
Check692.24MB
Check951.97MB
Check484.94MB
Check241.15MB
Check377.34MB
Check438.74MB
Check389.42MB
Check412.88MB
Check562.26MB
Check349.36MB
Check933.92MB
Check254.22MB
Check736.89MB
Check484.31MB
Check853.43MB
Check716.85MB
Check755.33MB
Check881.98MB
Check377.51MB
Check833.93MB
Check425.43MB
Check236.47MB
Check254.56MB
Check119.95MB
Check617.43MB
Check885.24MB
Check572.32MB
Check776.45MB
CheckScan to install
HS code-driven letter of credit checks to discover more
Netizen comments More
505 How to utilize blockchain for trade
2024-12-23 22:27 recommend
2279 Data-driven multimodal transport decisions
2024-12-23 22:26 recommend
1395 Trade analytics for risk mitigation
2024-12-23 22:05 recommend
1259 HS code-based vendor qualification
2024-12-23 21:37 recommend
1118 HS code-based market share analysis
2024-12-23 20:09 recommend